Neurological Disorders
Regenerative Support for
the Neurological System.
Neurodegenerative conditions — Parkinson's disease, Alzheimer's disease, dementia, and chronic neurological pain — share common biological roots: neuroinflammation, mitochondrial decline, and disrupted cellular communication.
Atunse's exosome-based neurological support program addresses these at the biological level — delivered via IV infusion for systemic reach and intranasal administration for direct-to-brain access. All protocols are physician-governed, ethically communicated, and individually assessed.
Dementia · Parkinson's Disease · Alzheimer's · Chronic Pain Management
Neurological Support — Exosome Therapy
A physician-designed program integrating IV and intranasal exosome delivery with precision lifestyle optimization — built for individuals seeking advanced exosome-based supportive care for neurological conditions including dementia, Parkinson's disease, Alzheimer's disease, and chronic neurological pain. All protocols are governed by physician assessment, ethical consent, and individual clinical eligibility.
- IV exosome infusions for systemic delivery and broad neurological signaling support
- Intranasal exosome delivery for targeted, direct-to-brain access via the olfactory pathway
- Dual-route protocol — combining systemic and central nervous system delivery
- Physician-led, individually assessed neurological support protocol
- Designed to support cognitive function and neurological health
- May help modulate neuroinflammatory pathways
- Chronic pain management support through neuroregenerative signaling
- Precision nutrition and anti-inflammatory lifestyle optimization
- Integrated with KIARMA Know, Rebuild & Audit domains
At Atunse — The Regenerative Core
Exosome Support Therapy is the regenerative core of this program — delivered via two complementary routes: IV infusion for systemic neurological signaling support, and intranasal administration for direct-to-brain delivery via the olfactory pathway. This dual-route approach maximizes reach across both the peripheral and central nervous system environments.
Pricing
Pricing available after consultation
Conditions We Support
Neurological Conditions,
Approached Biologically.
Dementia
Dementia encompasses a spectrum of progressive cognitive decline, much of which involves neuroinflammation and disrupted cellular communication pathways. Exosome therapy is explored as a supportive biological strategy within the broader care framework.
Supportive care program — not curativeParkinson's Disease
Parkinson's disease involves the progressive loss of dopaminergic neurons and systemic neuroinflammatory burden. Exosome-based interventions are being studied for their potential to support neuronal environments and modulate inflammatory signaling in affected individuals.
Supportive care program — adjunct to specialist managementAlzheimer's Disease
Alzheimer's involves complex amyloid and tau pathologies alongside neuroinflammation. Exosome therapy aims to support the broader neurological tissue environment — addressing cellular signaling, mitochondrial health, and systemic inflammation as a complementary biological strategy.
Supportive care program — not curativeChronic Neurological Pain
Chronic pain with a neurological basis — including neuropathic pain, central sensitization, and pain from degenerative conditions — represents a major quality-of-life burden. Exosome therapy is applied to support pain modulation pathways, inflammatory signaling, and tissue environments contributing to the pain experience.
Supportive modulation — individualized protocolThe Science
How Exosome Therapy
Supports the Brain.
Delivery Route 1
IV Infusion
Intravenous exosome delivery provides systemic distribution — supporting neurological tissue environments via bloodstream circulation. IV infusion is the foundational delivery route, ensuring broad biological availability across the body's systemic and peripheral nervous system environments.
Delivery Route 2
Intranasal Administration
Intranasal delivery leverages the olfactory pathway as a direct route to the brain — bypassing the blood-brain barrier. This allows exosomes to reach central nervous system environments more directly, complementing IV infusion with targeted neurological access for conditions affecting brain tissue and cognition.
Neuroinflammation Modulation
Exosomes carry anti-inflammatory signaling molecules that can cross the blood-brain barrier and modulate the neuroinflammatory environment associated with most neurodegenerative conditions.
Mitochondrial Support
Mitochondrial dysfunction is a shared hallmark of neurodegeneration. Exosome-mediated signaling supports mitochondrial biogenesis and cellular energy metabolism in neuronal environments.
Cellular Communication Restoration
Exosomes are the body's natural cellular communication vehicles. Supplementing the signaling environment can support disrupted neural communication pathways in affected brain regions.
Neuroprotective Signaling
Exosome-derived factors include proteins and nucleic acids with documented neuroprotective properties — supporting neuronal survival, synaptic health, and cellular repair mechanisms.
Exosome therapy for neurological conditions is an investigational therapeutic category. Atunse's neurological support programs are supportive care protocols — not curative treatments. All protocols are conducted under physician oversight, with documented consent and individual clinical eligibility assessment. Patients with active neurological conditions should continue management under their specialist care team. Outcomes are not guaranteed.
Your Pathway Starts Here
Every Program Begins
With Assessment.
Clinical eligibility, program suitability, and individual care pathways are determined through consultation with an Atunse physician. Honest, evidence-informed guidance is our standard — not commercial enthusiasm.